| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 58,682 | 57,963 | 52,142 | 57,712 | | Cost of Revenue | 3,241 | 3,587 | (1,319) | 2,295 | | | Gross Profit | 55,441 | 54,376 | 53,461 | 55,417 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,785 | 5,305 | 6,026 | 5,242 | | Non Recurring | 1,064 | 731 |
-
|
-
| | Others | 12,146 | 11,819 | 12,361 | 11,384 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 36,446 | 36,521 | 35,074 | 38,791 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,478 | 2,765 | 6,165 | 818 | | Earnings Before Interest And Taxes | 36,862 | 36,868 | 35,775 | 39,609 | | Interest Expense | 15,435 | 15,431 | 13,660 | 14,791 | | Income Before Tax | 21,427 | 21,437 | 22,115 | 24,818 | | Income Tax Expense | (545) | (537) | (1,426) | (1,654) | | Minority Interest | 175 | (175) | (350) | (114) | | | | Net Income From Continuing Ops | 24,316 | 24,320 | 28,739 | 26,458 | | | Non-recurring Events | | Discontinued Operations | 2,783 | 2,484 | 128 | 3,816 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,099 | 26,804 | 28,867 | 30,274 | | Preferred Stock And Other Adjustments | (146) |
-
| (6,785) | 3,392 | | | Net Income Applicable To Common Shares | $26,953 | $26,804 | $22,082 | $33,666 |
|
0.02% Nasdaq 0.00%
Income Statement
